Finanzas: More on Rite Aid’s Q2


Rite Aid (NYSE:RAD) reports same-store sales declined 2.5% in Q2.

Comparable front-end sales +0.1% and pharmacy comp down 3.6%.


Retail pharmacy sales slipped 2.5% to $6.49B due to decrease in same store sales.

RELACIONADA: Finanzas: Rite Aid Reports Fiscal 2017 Second Quarter Results

Prescription sales accounted for 68.5% of total drugstore sales.

Gross margin rate squeezed 120 bps to 23.9%.

SG&A expense rate improved 40 bps to 22.1%.

Adjusted EBITDA fell 9.8% to $312.7M.

Store count: Wellness centers +355 Y/Y to 2,214; Total stores -11 Y/Y to 4,550.

RAD +0.49% premarket.

Fuente: Seeking Alpha

Reciba las últimas noticias de la industria en su casilla:

Suscribirse ✉


Please enter your comment!
Please enter your name here